CClinicalTrials.gg
CompletedNCT05310838Updated Aug 27, 2026

Optimizing Engagement in Services for First-Episode Psychosis

An interventional study of Behavioral Activation for First Episode Psychosis and Treatment As Usual in Engagement, Patient and First Episode Psychosis, sponsored by California State University, San Bernardino. Completed at 2 sites in United States. Open to participants aged 15 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by California State University, San Bernardino · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
15 Years to 35 Years
Sex
All
01

Study summary

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

Read the detailed description

After an initial pre-screen, screening, and pre-intervention assessment, enrolled participants will be randomized to either BA or TAU. The study intervention phase will last up to 6 months, during which time BA participants will receive up to 12 one-on-one BA sessions and TAU participants will receive the usual care (e.g., medication management and any other service [e.g., group counseling]). Participants will be assessed at post-intervention, 1-month-post-intervention, and 6-month-post-intervention. The primary objective of aim 1 is to examine whether BA for FEP improves engagement in services better than TAU among Latinos with FEP and their families. Secondary objectives of aim 1 are to examine whether BA participants show greater improvements in quality of life, symptoms (e.g., psychosis, depression), functioning, and recovery compared to TAU participants, and whether BA participants have greater remission rates than the TAU group at 1- and 6-month post-intervention. Additionally, the association between potential BA mediators and engagement will be examined to identify mechanisms of engagement. Potential predictors of engagement will also be examined.

02

Conditions studied

  • Engagement, Patient
  • First Episode Psychosis

Browse trials for

Keywords

  • First Episode Psychosis
  • Behavioral Activation
  • Engagement
  • Latinx
03

In context

Patient Participation

127 studies on the registry are indexed under Patient Participation; 64 are open to participants now.

This study's enrollment of 28 is below the median of 138 across 105 interventional studies indexed under Patient Participation.

Browse Patient Participation studies →

Lead sponsor

California State University, San Bernardino is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Self-identification as Latino
  • Age 15 to 35
  • Diagnostic \& Statistical Manual of Mental Disorders-5 diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, other specified schizophrenia spectrum, affective psychosis, and other psychotic disorder criteria
  • Ability to speak English or Spanish
  • Caregiver willing to consent to participate in the study and care
  • Ability to provide fully informed consent

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of psychotic disorder due to another medical condition or substance/medication-induced psychotic disorder
  • Presence of a serious medical condition
  • 3≤ years after the onset
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Behavioral Activation for First Episode Psychosis

    Patients will receive BA for FEP in individual session format provided by the PI based on a manual adapted for this study.

    Behavioral: Behavioral Activation for First Episode Psychosis

  • Active comparator
    Treatment at Usual

    Patients randomized to TAU will receive typical clinic care offered beyond psychiatric services.

    Behavioral: Treatment As Usual

Interventions

  • BehavioralBehavioral Activation for First Episode Psychosis

    Sessions will be offered weekly and dyads can complete the intervention during a 6-month period to accommodate competing demands encountered by the population.

  • BehavioralTreatment As Usual

    Given this condition, patients may also receive individual rehabilitation and/or group psychosocial interventions as part of typical clinic care.

06

What researchers measure

Primary outcomes

  1. Change in Engagement on the Patient Activation Measure (PAM13) at Post-Intervention

    PAM13 is a 13-item self-report short form of a patient's engagement in the care process at four stages. PAM13 shows high reliability that is stable across chronic illnesses and high construct validity, and measures change over time. Items are rated on a 4-point Likert scale (totally disagree to totally agree) with higher scores reflecting higher activation; respondent may select 'not applicable.'

    Time frame: Change from Pre-intervention PAM13 at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  2. Change in Engagement on the Patient Activation Measure (PAM13) at 1-Month Post-Intervention

    PAM13 is a 13-item self-report short form of a patient's engagement in the care process at four stages. PAM13 shows high reliability that is stable across chronic illnesses and high construct validity, and measures change over time. Items are rated on a 4-point Likert scale (totally disagree to totally agree) with higher scores reflecting higher activation; respondent may select 'not applicable.'

    Time frame: Change from Pre-intervention PAM13 at 1-month-post-intervention

  3. Change in Engagement on the Patient Activation Measure (PAM13) at 6-Months Post-Intervention

    PAM13 is a 13-item self-report short form of a patient's engagement in the care process at four stages. PAM13 shows high reliability that is stable across chronic illnesses and high construct validity, and measures change over time. Items are rated on a 4-point Likert scale (totally disagree to totally agree) with higher scores reflecting higher activation; respondent may select 'not applicable.'

    Time frame: Change from Pre-intervention PAM13 at 6-months-post-intervention

  4. Engagement as measured by the Service Engagement Scale (SES)

    The 14-item provider rated SES has demonstrated good reliability and validity and reflects client availability, collaboration, help-seeking, and adherence. Items are rated on a 4-point Likert scale with higher scores reflecting clients' greater levels of difficulty engaging with services. The SES is a secondary measure of service engagement.

    Time frame: Weekly per session up to 12 sessions, up to 6 months

Secondary outcomes

  1. Change in Quality of Life on the Heinrichs-Carpenter Quality of Life Scale (QLS) at Post-Intervention

    The QLS is a 21-item, clinician-administered, semi-structured interview on a 7-point scale with higher scores reflecting normal or unimpaired functioning. It has shown high sensitivity to change and treatment effect. The total score is the main secondary outcome of interest.

    Time frame: Change from Pre-intervention QLS at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  2. Change in Quality of Life on the Heinrichs-Carpenter Quality of Life Scale (QLS) at 1-Month Post-Intervention

    The QLS is a 21-item, clinician-administered, semi-structured interview on a 7-point scale with higher scores reflecting normal or unimpaired functioning. It has shown high sensitivity to change and treatment effect. The total score is the main secondary outcome of interest.

    Time frame: Change from Pre-intervention QLS at 1-month-post-intervention

  3. Change in Quality of Life on the Heinrichs-Carpenter Quality of Life Scale (QLS) at 6-Months Post-Intervention

    The QLS is a 21-item, clinician-administered, semi-structured interview on a 7-point scale with higher scores reflecting normal or unimpaired functioning. It has shown high sensitivity to change and treatment effect. The total score is the main secondary outcome of interest.

    Time frame: Change from Pre-intervention QLS at 6-months-post-intervention

  4. Change in Quality of Life on the Modified Lehman Quality of Life Inventory (QOLI-M) at Post-Intervention

    The QOLI-M has well established psychometric properties with individuals with serious mental illness (SMI) and will be used to derive overall subjective quality of life and objective and subjective quality of social and family interaction ratings. The QOLI-M, not the QLS, assesses general quality of life which focuses on areas beyond those affected by psychotic illness.

    Time frame: Change from Pre-intervention QOLI-M at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  5. Change in Quality of Life on the Modified Lehman Quality of Life Inventory (QOLI-M) at 1-Month Post-Intervention

    The QOLI-M has well established psychometric properties with individuals with serious mental illness (SMI) and will be used to derive overall subjective quality of life and objective and subjective quality of social and family interaction ratings. The QOLI-M, not the QLS, assesses general quality of life which focuses on areas beyond those affected by psychotic illness.

    Time frame: Change from Pre-intervention QOLI-M at 1-month-post-intervention

  6. Change in Quality of Life on the Modified Lehman Quality of Life Inventory (QOLI-M) at 6-Months Post-Intervention

    The QOLI-M has well established psychometric properties with individuals with serious mental illness (SMI) and will be used to derive overall subjective quality of life and objective and subjective quality of social and family interaction ratings. The QOLI-M, not the QLS, assesses general quality of life which focuses on areas beyond those affected by psychotic illness.

    Time frame: Change from Pre-intervention QOLI-M at at 6-months-post-intervention

  7. Change in Symptoms on the Positive And Negative Syndrome Scale (PANSS) at Post-Intervention

    This 30-item widely-used clinician-administered instrument measures psychosis symptom severity and remission. Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Change from Pre-intervention PANSS at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  8. Change in Symptoms on the Positive And Negative Syndrome Scale (PANSS) at 1-Month Post-Intervention

    This 30-item widely-used clinician-administered instrument measures psychosis symptom severity and remission. Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Change from Pre-intervention PANSS at 1-month-post-intervention

  9. Change in Symptoms on the Positive And Negative Syndrome Scale (PANSS) at 6-Months Post-Intervention

    This 30-item widely-used clinician-administered instrument measures psychosis symptom severity and remission. Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Change from Pre-intervention PANSS at 6-months-post-intervention

  10. Change in Functioning on the Strauss-Carpenter level of Function Scale (Strauss-Carpenter) at Post-Intervention

    The Strauss-Carpenter is a semi-structured interviewer-administered scale that assesses functioning in social contacts, work, symptomatology, and function. Items are rated on a five-point scale (0-4) with higher scores reflecting better functioning.

    Time frame: Change from Pre-intervention Strauss-Carpenter at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  11. Change in Functioning on the Strauss-Carpenter level of Function Scale (Strauss-Carpenter) at 1-Month Post-Intervention

    The Strauss-Carpenter is a semi-structured interviewer-administered scale that assesses functioning in social contacts, work, symptomatology, and function. Items are rated on a five-point scale (0-4) with higher scores reflecting better functioning.

    Time frame: Change from Pre-intervention Strauss-Carpenter at 1-month-post-intervention

  12. Change in Functioning on the Strauss-Carpenter level of Function Scale (Strauss-Carpenter) at 6-Months Post-Intervention

    The Strauss-Carpenter is a semi-structured interviewer-administered scale that assesses functioning in social contacts, work, symptomatology, and function. Items are rated on a five-point scale (0-4) with higher scores reflecting better functioning.

    Time frame: Change from Pre-intervention Strauss-Carpenter at 6-months-post-intervention

  13. Change in Depression on the Calgary Depression Scale (CDS) at Post-Intervention

    The CDS is an interview-based 9-item scale that measures depression severity in people with schizophrenia and is valid and reliable. Items are rated on a four-point scale with higher scores reflecting greater severity of symptoms.

    Time frame: Change from Pre-intervention CDS at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  14. Change in Depression on the Calgary Depression Scale (CDS) at 1-Month Post-Intervention

    The CDS is an interview-based 9-item scale that measures depression severity in people with schizophrenia and is valid and reliable. Items are rated on a four-point scale with higher scores reflecting greater severity of symptoms.

    Time frame: Change from Pre-intervention CDS at 1-month-post-intervention

  15. Change in Depression on the Calgary Depression Scale (CDS) at 6-Months Post-Intervention

    The CDS is an interview-based 9-item scale that measures depression severity in people with schizophrenia and is valid and reliable. Items are rated on a four-point scale with higher scores reflecting greater severity of symptoms.

    Time frame: Change from Pre-intervention CDS at 6-months-post-intervention

  16. Change in Recovery as measured by the Maryland Assessment of Recovery in People with SMI (MARS) at Post-Intervention

    The 25-item patient-report MARS measures recovery and has excellent internal consistency and test-retest reliability and good face and content validity. Items are rated on a five-point scale with higher scores reflecting greater self-reported recovery.

    Time frame: Change from Pre-intervention MARS at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  17. Change in Recovery as measured by the Maryland Assessment of Recovery in People with SMI (MARS) at 1-Month Post-Intervention

    The 25-item patient-report MARS measures recovery and has excellent internal consistency and test-retest reliability and good face and content validity. Items are rated on a five-point scale with higher scores reflecting greater self-reported recovery.

    Time frame: Change from Pre-intervention MARS at 1-month-post-intervention

  18. Change in Recovery as measured by the Maryland Assessment of Recovery in People with SMI (MARS) at 6-Months Post-Intervention

    The 25-item patient-report MARS measures recovery and has excellent internal consistency and test-retest reliability and good face and content validity. Items are rated on a five-point scale with higher scores reflecting greater self-reported recovery.

    Time frame: Change from Pre-intervention MARS at 6-months-post-intervention

  19. PANSS-based Remission Rates at Post-Intervention

    Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Remission at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  20. PANSS-based Remission Rates at 1-Month Post-Intervention

    Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Remission at 1-month-post-intervention

  21. PANSS-based Remission Rates at 6-Months Post-Intervention

    Scores 4 ≤ on delusions, conceptual disorganization, hallucinatory behavior, mannerisms \& posturing, and unusual thought content will be considered in remission.

    Time frame: Remission at 6-months-post-intervention

Other outcomes

  1. Change in Activation as measured by the Behavioral Activation for Depression Scale-Short Form (BADS-SF) at Post-Intervention

    The 9-item self-report BADS-SF tracks when and how changes in activation occur (7-point scale; not at all to completely). It has shown good internal consistency reliability, construct validity, and predictive validity. BADS-SF is the primary measure of activation.

    Time frame: Change from Pre-intervention BADS-SF at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  2. Change in Activation as measured by the Behavioral Activation for Depression Scale-Short Form (BADS-SF) at 1-Month Post-Intervention

    The 9-item self-report BADS-SF tracks when and how changes in activation occur (7-point scale; not at all to completely). It has shown good internal consistency reliability, construct validity, and predictive validity. BADS-SF is the primary measure of activation.

    Time frame: Change from Pre-intervention BADS-SF at 1-month-post-intervention

  3. Change in Activation as measured by the Behavioral Activation for Depression Scale-Short Form (BADS-SF) at 6-Months Post-Intervention

    The 9-item self-report BADS-SF tracks when and how changes in activation occur (7-point scale; not at all to completely). It has shown good internal consistency reliability, construct validity, and predictive validity. BADS-SF is the primary measure of activation.

    Time frame: Change from Pre-intervention BADS-SF at 6-months-post-intervention

  4. Activation as measured by the Behavioral Activation Homework Completion Observer-Based Coding System (BA HC)

    BA HC permits reliable coding of the characterization and completion of BA homework, including type of assignment, realm of functioning it targets, and the extent of homework completion. It will be used as a secondary measure of activation for BA.

    Time frame: Weekly per session up to 12 sessions, up to 6 months

  5. Change in Environmental Reward as measured by the Reward Probability Index (RPI) at Post-Intervention

    RPI is a 20-item self-report measure of contact with environmental reward, which is theorized to maintain healthy behavior per behavioral models of psychopathology, with good internal consistency, test-retest reliability, and discriminant, predictive, and convergent validity. Items are rated on a 4-point Likert scale with higher scores indicating higher levels of reinforcement.

    Time frame: Change from Pre-intervention RPI at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  6. Change in Environmental Reward as measured by the Reward Probability Index (RPI) at 1-Month Post-Intervention

    RPI is a 20-item self-report measure of contact with environmental reward, which is theorized to maintain healthy behavior per behavioral models of psychopathology, with good internal consistency, test-retest reliability, and discriminant, predictive, and convergent validity. Items are rated on a 4-point Likert scale with higher scores indicating higher levels of reinforcement.

    Time frame: Change from Pre-intervention RPI at 1-month-post-intervention

  7. Change in Environmental Reward as measured by the Reward Probability Index (RPI) at 6-Months Post-Intervention

    RPI is a 20-item self-report measure of contact with environmental reward, which is theorized to maintain healthy behavior per behavioral models of psychopathology, with good internal consistency, test-retest reliability, and discriminant, predictive, and convergent validity. Items are rated on a 4-point Likert scale with higher scores indicating higher levels of reinforcement.

    Time frame: Change from Pre-intervention RPI at 6-months-post-intervention

  8. Change in medication adherence as measured by the Brief Adherence Rating Scale (BARS) at Post-Intervention

    The 4-item BARS is a brief, clinician-administered instrument to assess oral antipsychotic medication adherence and has good sensitivity (73%) and specificity (74%) in identifying non-adherent outpatients (defined as \<70% mean electronic monitoring adherence).

    Time frame: Change from Pre-intervention BARS at Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  9. Change in medication adherence as measured by the Brief Adherence Rating Scale (BARS) at 1-Month Post-Intervention

    The 4-item BARS is a brief, clinician-administered instrument to assess oral antipsychotic medication adherence and has good sensitivity (73%) and specificity (74%) in identifying non-adherent outpatients (defined as \<70% mean electronic monitoring adherence).

    Time frame: Change from Pre-intervention BARS at 1-month-post-intervention

  10. Change in medication adherence as measured by the Brief Adherence Rating Scale (BARS) at 6-Months Post-Intervention

    The 4-item BARS is a brief, clinician-administered instrument to assess oral antipsychotic medication adherence and has good sensitivity (73%) and specificity (74%) in identifying non-adherent outpatients (defined as \<70% mean electronic monitoring adherence).

    Time frame: Change from Pre-intervention BARS at 6-months-post-intervention

  11. Alliance as measured by the Working Alliance Inventory - Short Form (WAI-SF)

    The 12-item WAI-SF measures agreement on goals and tasks of therapy and the bond between the therapist and the client and has demonstrated good reliability and convergent validity. Items are rated on a 5-point Likert scale with higher scores indicating a better therapeutic alliance. The WAI-SF will be used to assess the patient-provider alliance.

    Time frame: Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  12. Person-centered care as measured by the Combined Assessment of Psychiatric Environments (CAPE)

    CAPE assesses patient perspective patient-centered care and shows internal consistency reliability, test-retest reliability, and construct and criterion validity.

    Time frame: Post-intervention (after 12th session or 6-months after start of intervention, whichever comes first)

  13. Family involvement

    Family involvement, or whether a family member was present at a service encounter, will be assessed by an independent observer based on review of service. This method has been used in prior early intervention studies.

    Time frame: Weekly per session up to 12 sessions, up to 6 months

07

Study locations

2 sites
  • San Fernando Mental Health Center
    Granada Hills, California 91344, United States
  • Olive View - UCLA Medical Center
    Sylmar, California 91342, United States
08

References and documents

Study documents

  • Informed consent form · Mar 21, 2025
  • Informed consent form · Mar 21, 2025
  • Informed consent form · Mar 21, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05310838
Lead sponsor
California State University, San Bernardino
Collaborators
University of Southern California, Olive View-UCLA Education & Research Institute, National Institute of Mental Health (NIMH)
Responsible party
Maria Santos (Assistant Professor, California State University, San Bernardino) — Principal investigator
First posted
Apr 5, 2022
Start date
Mar 1, 2022
Primary completion
Dec 16, 2025
Completion
Jun 16, 2026
Last update
Aug 27, 2026

Study contacts

Maria Santos, PhD
principal investigator · California State University, San Bernardino

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion